The Tax Cuts and Jobs Act of 2017 reconfigured the tax code. Did it also enable a pharmaceutical giant to invest in Wake ...

As Sandoz gears up to launch one of the most anticipated biosimilars of the year, the company could face near-term ...

US biotech major Amgen =announced that it has reached resolution of its patent infringement litigation related to South Korea ...

Amgen Inc . (NASDAQ:AMGN), a leading biotechnology company with a market capitalization of $151.3 billion, is navigating a ...

Amgen (Nasdaq: AMGN) has completed construction of a $550 million drug manufacturing facility in the Wake County town.

Amgen’s Blincyto (blinatumomab) has been approved by the European Commission (EC) to treat certain acute lymphoblastic ...

We expect Amgen AMGN to beat expectations when it reports fourth-quarter and full-year 2024 results on Feb. 4, after market ...

Three years after beginning construction in southwestern Wake County, the pharmaceutical company Amgen celebrated the ...

Getting the merger over the line will be a relief to the pharma sector ... its adjusted earnings per share from 2024 onwards. Amgen’s products in inflammation include severe asthma therapy ...

Amgen's stock price remains ... analysts are often very cautious about pharmaceutical companies. Due to patent losses and not really knowing how new products will perform, analysts are often ...